74831 Procurement Plan IDA CRISS RESPONSE WINDOW RESOURCES TO THE REPUBLIC OF KENYA FOR A HEALTH SECTOR SUPPORT PROJECT I. General 1. Project information: Country: Kenya CREDIT No. 4771-KE Project ID No. P074091 Project Implementing Agency (PIA): Kenya Medical Supplies Agency (KEMSA) 2. Bank’s approval Date of the procurement Plan [Original : 30th November 2011; Revision 1- 21st November 2012. 3. Date of General Procurement Notice: 28th September 2010 4. Period covered by this procurement plan: 12 months II. Goods and Works and non-consulting services. 1. Prior Review Threshold: Procurement Decisions subject to Prior Review by the Bank as stated in Appendix 1 to the Guidelines for Procurement: [Thresholds for applicable procurement methods (not limited to the list below) will be determined by the Procurement Specialist /Procurement Accredited Staff based on the assessment of the implementing agency’s capacity.] Procurement Method Prior Review Threshold Comments 1. ICB and LIB (Goods) >$ 500,000 2. NCB (Goods) >$80000 - < $500,000 Post review 3. ICB (Works) N/A 4. NCB (Works) N/A 5. ICB (Non-Consultant Services) N/A [Add other methods if necessary] 2. Pre-qualification : NOT APPLICABLE 3. Proposed Procedures for CDD Components (as per paragraph. 3.17 of the Guidelines: Procurement under IBRD Loans and IDA Credits dated May 2004 revised October 2006 and May 2010) 4. Reference to (if any) Project Operational/Procurement Manual: Procurement under IBRD Loans and IDA Credits dated May 2004 revised October 2006 and May 2010 5. Any Other Special Procurement Arrangements: NOT APPLICABLE 6. Procurement Packages with Methods and Time Schedule Re f. Preq No ualifi Domestic Proc IDA Submit/Open . Contract (Description) catio Preference Comments Method Review bids n (yes/no) (yes/ no) Nutritional A Supplements KEMSA/KHSSP- Multivitamin & CRW-OIT- Mineral 01/2012-2013 Supplements 1 ICB Yes ICB Prior 8-Feb-13 B ANTI TB DRUGS FIRST LINE ANTI TB 1 DRUGS ICB No Yes Prior 19-Jul-12 SECOND LINE ANTI TB 2 DRUGS ICB No Yes Prior 8-Feb-13 EMMS- PHARMACEUTICAL AND NON C PHARMACEUTICALS KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 02/2012-2013 (Tablets - 1 General) ICB No Yes Prior 8-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 03/2012-2013 (Tablet/Capsule s (Anti 2 Infectives) ICB No Yes Prior 15-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 04/2012-2013 (Syrups/Suspen 3 sion) ICB No Yes Prior 15-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 05/2012-2013 (Injectables 4 (Antibiotics) ICB No Yes Prior 15-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 06/2012-2013 (Injectables 5 (General) ICB No Yes Prior 15-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 07/2012-2013 ( IV Infusions) 6 NCB No Yes Post 22-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 08/2012-2013 (Disinfectants 7 and Antiseptics) ICB No Yes Prior 22-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceuticals 09/2012-2013 (Ointment/Crea ms/Lotion/Drop s/Pessaries/Inha lers(External 8 Application) ICB No Yes Prior 22-Feb-13 KEMSA/KHSSP- Supply of Non CRW-OIT- Pharmaceuticals 9 10/2012-2013 (Loose) ICB No Yes Prior 8-Feb-13 KEMSA/KHSSP- Supply of CRW-OIT- Pharmaceutical 11/2012-2013 Packaging 10 Materials NCB No Yes Post 22-Feb-13 EMMS FOR EMERGENCY D RESPONSE LEVEL 4-5 Supply of Tender Pharmaceuticals under 1 EMMS ( Loose) ICB No Yes Prior 27-Aug-12 evaluation III. Selection of Consultants NOT APPLICABLE 1. Prior Review Threshold: Selection decisions subject to Prior Review by Bank as stated in Appendix 1 to the Guidelines Selection and Employment of Consultants: Selection Method Prior Review Threshold Comments 1. Competitive Methods (Firms) 2. Single Source (Firms) [Add specific methods if necessary] 2. Short list comprising entirely of national consultants: Short list of consultants for services, estimated to cost less than $_______equivalent per contract, may comprise entirely of national consultants in accordance with the provisions of paragraph 2.7 of the Consultant Guidelines. 3. Any Other Special Selection Arrangements: [including advance procurement and retroactive financing, if applicable] 4. Consultancy Assignments with Selection Methods and Time Schedule 1 2 3 4 5 6 7 Ref. No. Description of Estimated Selection Review Expected Comments Assignment Cost Method by Bank Proposals (Prior / Submission Post) Date IV. Implementing Agency Capacity Building Activities with Time Schedule 1. In this section the agreed Capacity Building Activities (some items could be from CPAR recommendation) are listed with time schedule No. Expected outcome / Estimated Estimated Start Date Comments Activity Description Cost Duration